Log In
Print
BCIQ
Print
Print this Print this
 

CEP-32496

  Manage Alerts
Collapse Summary General Information
Company Ambit Biosciences Corp.
DescriptionDual inhibitor of BRAF and EGFR
Molecular Target BRAF
Mechanism of ActionBRAF inhibitor
Latest Stage of DevelopmentIND
IndicationMelanoma
Partner

Teva Pharmaceutical Industries Ltd.
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today